3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
4
Lymphoma, Large-Cell, Anaplastic
2
Immunoblastic Lymphadenopathy
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Follicular
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
pembrolizumab
23
Nivolumab
14
enfortumab vedotin
13
Gemcitabine
11
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
Cisplatin
8
Carboplatin
8
avelumab
7
sacituzumab govitecan
6
Docetaxel
6
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
Immunoglobulin G
3
CTLA-4 Antigen
3
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Fluorouracil
2
Disulfides
2
Cyclophosphamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
10-propargyl-10-deazaaminopterin
×
90 days
×
Clear all
No trials found.